Purpose
to conduct a Phase I HIV vaccine study that will compare the immunogenicity of different centralized gene (env) constructs
Grantee
Division
Global Health
Date
NOVEMBER 2009
Region served
GLOBAL
Committed amount
$7,318,861
Grant topic
HIV
Duration (months)
100
Grantee location
Durham, North Carolina, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.